Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThames Wat.u 35 Regulatory News (AW14)

Share Price Information for Thames Wat.u 35 (AW14)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
AW14 Live PriceLast checked at - London Stock Exchange

Intraday Thames Wat.u 35 Share Chart

Process Update

20 Sep 2024 07:02

RNS Number : 0242F
Thames Water Utilities Limited
20 September 2024
 

Thames Water Utilities Limited

20 September 2024

Process Update

 

We previously announced that following the Price Review 2024 ("PR24") draft determination and our response to Ofwat, we would be engaging with potential investors and creditors to seek new equity and to extend our liquidity runway.

 

We submitted our response to Ofwat's draft determination for 2025 to 2030 on 28 August 2024. We plan to launch our formal equity solicitation process in the coming weeks. Any equity process is not expected to conclude until after the Final Determination, originally due in December 2024, which Ofwat are consulting on moving to January 2025. We will have the option to request an appeal of the Final Determination to the CMA.

 

We have been engaging with financial stakeholder groups and their advisors since July 2024 and are assisting with information requests to enable financial stakeholder groups to better understand Thames Water's business plan and future funding needs.

 

As at 31 August 2024, we had £1.57 billion of liquidity consisting of £1.15 billion of cash and cash equivalents (£0.38 billion of which is currently required to be placed in reserves under our financing) and £0.42 billion of Class A and Class B undrawn committed facilities. A further £0.55 billion of undrawn reserve liquidity facilities are available to support Thames Water should we enter standstill under our financing. The combination of these resources provides a liquidity runway to May 2025.

 

As contingency planning, we have entered into discussions with our financial stakeholders to release cash reserves under our financing. This would require majority creditor consent. If consent were not forthcoming and should it not be possible to draw the Class A and/or Class B facilities, available cash and cash equivalents would expire at the end of December 2024, whereupon we would enter standstill under our financing and the £0.55 billion undrawn reserve liquidity facilities and £0.38 billion of cash reserves would become available.

 

We, together with our financial stakeholders, are considering options for the extension of our liquidity runway to enable time to complete a recapitalisation transaction. In parallel, we continue to undertake contingency planning as a matter of good corporate practice.

 

For further information

Investor enquiries

Frederick Maroudas - Director of Corporate Finance debt.investorrelations@thameswater.co.uk

Media enquiries

Simon Haynes - Media Relations Manager07747644910simon.haynes@thameswater.co.uk

Matt Young - Apella Advisors07802 332292 my@apellaadvisors.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFIFEEAAIIFIS
12
Date   Source Headline
27th Dec 20247:01 amRNSLiquidity Extension Update
27th Dec 20247:00 amRNSLiquidity Extension Update
20th Dec 20243:02 pmRNSTWUL - STID Proposal
19th Dec 20248:00 amRNSPR24 Final Determination
17th Dec 20246:13 pmRNSLiquidity Extension Update
17th Dec 20241:44 pmRNSLiquidity Extension Update
17th Dec 202410:00 amRNSLiquidity Extension Update
16th Dec 20244:57 pmRNSLiquidity Extension Update
13th Dec 20244:35 pmRNSLiquidity Extension Update
10th Dec 20247:19 amRNSInterim Financial Statements
10th Dec 20247:04 amRNSInterim Financial Statements
22nd Nov 202411:20 amRNSLiquidity Extension Update
18th Nov 20243:41 pmRNSSTID Proposal - Results Announcement
13th Nov 20247:00 amRNSLiquidity Extension Update
25th Oct 20243:14 pmRNSSTID Proposal - Notice of Bondholder Meetings
25th Oct 20243:12 pmRNSSTID Proposal Launch Announcement
25th Oct 20247:00 amRNSLiquidity Extension Update
30th Sep 202410:16 amRNSAnnual Financial Statements
20th Sep 20247:02 amRNSProcess Update
28th Aug 202412:28 pmRNSPR24 Draft Determination Response
31st Jul 20244:56 pmRNSS&P Ratings Action
24th Jul 202412:28 pmRNSMoody's ratings action
9th Jul 20247:00 amRNSAnnual Financial Report
9th Jul 20247:00 amRNSAnnual Financial Report
16th May 20247:00 amRNSDirector Change
22nd Apr 20247:00 amRNSPR24 Business Plan Update
28th Mar 20247:00 amRNSShareholder Funding Update
16th Feb 20248:00 amRNSCompany Information
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.